Advertisement
News
Subscribe to MDT Magazine News

Reportlinker Adds Global Immunoassay Systems Industry

September 30, 2010 8:31 am | by Bio-Medicine.Org | Comments

NEW YORK, Sept. 30 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Immunoassay Systems Industry http://www.reportlinker.com/p0305127/Global-Immunoassay-Systems-Industry.html This report analyzes the worldwide markets for Immunoassay...

TOPICS:

Generex bumps out Gluskin; Fletcher, Barratt fill CEO, chairman roles

September 30, 2010 7:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Worcester drug discovery firm Generex Biotechnology Corp. has named Mark Fletcher as CEO and interim president, replacing Generex co-founder, CEO, president and chairman Anna Gluskin.

Reportlinker Adds Global Protein Drugs Industry

September 30, 2010 7:32 am | by Bio-Medicine.Org | Comments

NEW YORK, Sept. 30 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Protein Drugs Industry http://www.reportlinker.com/p0305169/Global-Protein-Drugs-Industry.html This report analyzes the Global market for Protein Drugs in US$ Million...

TOPICS:
Advertisement

Minnow Medical Names Raymond W. Cohen as Chief Executive Officer

September 30, 2010 7:31 am | by Bio-Medicine.Org | Comments

LAGUNA HILLS, Calif., Sept. 30 /- Minnow Medical, Inc., a developer of a novel platform technology employing radiofrequency thermoplasty for the treatment of in-stent restenosis and other peripheral vascular conditions, announced today that veteran medical technology executive Raymond W....

TOPICS:

Meridian gets Canadian approval for molecular test

September 30, 2010 6:45 am | by The Associated Press | Comments

Meridian Bioscience Inc. said Thursday it has received Canadian regulatory approval to sell its illumigeneT molecular test for clostridium difficile, which can cause diarrhea and colon inflammation.The company said the approval will help it meet the needs of its clinical laboratory customers....

Disparities 2010: Interview with Joseph D. Rosenblatt, M.D.

September 30, 2010 6:32 am | by AACR | Comments

Disparities 2010: Interview with Joseph D. Rosenblatt, M.D., interim director, Sylvester Comprehensive Cancer Center.

TOPICS:

Dyax inks $106M development deal with Japan's CMIC

September 30, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Dyax Corp. has entered into a development and commercialization agreement worth a total of $106 million with Japanese firm CMIC Co. Ltd. to use subcutaneous DX-88 (ecallantide) to treat hereditary angioedema (HAE) and other angioedema indications in Japan.

Repligen Announces Completion of Patient Enrollment in Phase 2b Clinical Trial of RG2417 for Bipolar Depression

September 30, 2010 4:32 am | by Bio-Medicine.Org | Comments

WALTHAM, Mass., Sept. 30 /- Repligen Corporation (Nasdaq: RGEN ) reported today that it has completed enrollment of patients in its Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression.  This study is a double-blind,...

TOPICS:
Advertisement

caprotec bioanalytics Announces Commercial Launch of Three New caproKits™ for Applications in Functional Proteomics and Drug Development

September 30, 2010 4:32 am | by Bio-Medicine.Org | Comments

BERLIN and BURLINGTON, Mass., Sept. 30 / - caprotec bioanalytics GmbH announced today the commercial launch of three new caproKits™, enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development. The three new...

TOPICS:

Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships

September 30, 2010 4:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Sept. 30 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has engaged Fabiani & Company to assist in the establishment of federal partnerships...

TOPICS:

Winner Medical Launches Its Own PurCotton® B2C Website

September 30, 2010 4:31 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, Sept. 30 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner Medical"), a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton® materials for the medical and consumer products industries in China, today announced...

TOPICS:

Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R & D Alliance

September 30, 2010 1:32 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Sept. 30 /- Covance Inc. (NYSE: CVD ) today announced the signing of definitive agreements with sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) for Covance to become sanofi-aventis' R&D partner. Over the next ten years, Covance expects to provide drug development...

TOPICS:

Panasonic Toughbook CF-C1 Offers Tablet Computing For Gloved Workers And Removes The Cost Of Accidental Damage

September 30, 2010 1:31 am | by RealWire | Comments

Class Leading Convertible, Business Rugged Notebook Now Offers Multi-Touch Resistive Screen, Web Camera And 2 Year Accidental Damage Warranty Making It The Business-Ready TabletUK. 30TH SEPTEMBER 2010: Panasonic today enhanced its Toughbook CF-C1 range with a Multi-touch Resistive screen,...

TOPICS:

NIH funds center at Arizona State to battle infectious diseases

September 29, 2010 10:33 pm | by EurekAlert | Comments

(Arizona State University) Arizona State University has been awarded a $7.7 million grant for the next five years from the National Institute of General Medical Sciences, part of the National Institutes of Health, to unravel the structures of membrane proteins that play a key role...

TOPICS:

Dog ownership is associated with reduced eczema in children with dog allergies

September 29, 2010 9:31 pm | by EurekAlert | Comments

(Elsevier Health Sciences) Children with eczema have a greater risk of developing asthma and food allergies. The number of children with eczema is rising, but the reasons are unclear. A new study soon to be published in the Journal of Pediatrics examines the relationship between pet...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading